Tag: nasdaq:chrs

March 13, 2019

An Investor’s Overview to Biosimilars

Biosimilars are growing in popularity in both Canada and the US. Here is an overview of the biosimilars market for...
January 25, 2019

Coherus BioSciences Announces Global Settlement with AbbVie

Coherus BioSciences (Nasdaq:CHRS), a commercial biosimilar company, announced it has executed settlement agreements with AbbVie that grant Coherus global, non-exclusive...